ID   IGR/Cut40
AC   CVCL_A9AP
DR   cancercelllines; CVCL_A9AP
DR   IARC_TP53; 3786
DR   Wikidata; Q108820532
RX   PubMed=9581783;
RX   PubMed=21556589;
CC   Doubling time: ~28 hours (PubMed=21556589).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=21556589).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
RX   PubMed=9581783; DOI=10.1006/viro.1998.9086;
RA   Fogel S., Riou G.;
RT   "The early HPV16 proteins can regulate mRNA levels of cell cycle genes
RT   in human cervical carcinoma cells by p53-independent mechanisms.";
RL   Virology 244:97-107(1998).
//
RX   PubMed=21556589; DOI=10.3892/ijo.6.3.681;
RA   Fogel S., Ahomadegbe J.-C., Le Bihan M.-L., Barrois M., Riou G.;
RT   "Characterization of a new p53-mutated and HPV-negative human
RT   squamous-cell cervical carcinoma-derived cell-line.";
RL   Int. J. Oncol. 6:681-686(1995).
//